Obesity-related heart failure with preserved ejection fraction: diagnostic and therapeutic challenges
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Mi-Hyang | - |
dc.contributor.author | Shin, Mi-Seung | - |
dc.date.accessioned | 2024-02-14T00:00:35Z | - |
dc.date.available | 2024-02-14T00:00:35Z | - |
dc.date.issued | 2023-03 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.issn | 2005-6648 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90397 | - |
dc.description.abstract | The prevalence of heart failure with preserved ejection fraction (HFpEF) has increased in recent decades. In particular, obesity-related HFpEF is a distinct and frequently encountered phenotype; however, its diagnosis is complex. Furthermore, the management of obesity-related HFpEF has not been established despite the introduction of promising drugs. This review summarizes the diagnostic challenges, pathophysiology, and therapeutic options for obesity-related HFpEF. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한내과학회 | - |
dc.title | Obesity-related heart failure with preserved ejection fraction: diagnostic and therapeutic challenges | - |
dc.type | Article | - |
dc.identifier.wosid | 001150508700004 | - |
dc.identifier.doi | 10.3904/kjim.2022.271 | - |
dc.identifier.bibliographicCitation | The Korean Journal of Internal Medicine, v.38, no.2, pp 157 - 166 | - |
dc.identifier.kciid | ART002931894 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85149427359 | - |
dc.citation.endPage | 166 | - |
dc.citation.startPage | 157 | - |
dc.citation.title | The Korean Journal of Internal Medicine | - |
dc.citation.volume | 38 | - |
dc.citation.number | 2 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Obesity | - |
dc.subject.keywordAuthor | Heart failure | - |
dc.subject.keywordAuthor | Dyspnea | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordPlus | NATRIURETIC PEPTIDE | - |
dc.subject.keywordPlus | BARIATRIC SURGERY | - |
dc.subject.keywordPlus | DIASTOLIC FUNCTION | - |
dc.subject.keywordPlus | DIABETES-MELLITUS | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | EXERCISE | - |
dc.subject.keywordPlus | SPIRONOLACTONE | - |
dc.subject.keywordPlus | EMPAGLIFLOZIN | - |
dc.subject.keywordPlus | DAPAGLIFLOZIN | - |
dc.subject.keywordPlus | ALDOSTERONE | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.